Direct engagement of these receptors may reduce vascular inflammation, improve endothelial function, and modulate the processes driving atherosclerotic plaque development, independently of any changes in body weight
Lifestyle changes Non-medication approaches can also be effective for achieving weight loss goals
Department of Veterans Affairs on Thursday announced a new clinical trial to evaluate the efficacy of semaglutide, a GLP-1 receptor agonist used to treat diabetes, as treatment for alcohol use disorder (AUD)
With the surge in GLP-1 use, even traditional pharmacy categories are starting to show specialty-level cost trends
The most realistic approach includes a daily calorie deficit of around 8001,000 kcal, high protein intake (around 1.6 2.2 g per kg of body weight), regular training, and reduced sodium intake to help release retained water